A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors

Clinical trial NCT05318833 · COMPLETED

Trial details

NCT number: NCT05318833
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2022-05-12
Primary completion: 2025-03-20
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.